Related Experiment Video For Biomarker
Updated: Jan 8, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Identification of hub genes in peripheral blood and construction of a diagnostic nomogram model in ulcerative colitis
Xinglan Li1, Lu Ge1, Yingying Zhang1
1The People's Hospital of Danyang; Affiliated Danyang Hospital of Nantong University, Department of Gastroenterology, Danyang, Jiangsu, China.
Abstract:
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that significantly impacts patients' quality of life and incurs substantial healthcare costs. Currently, the diagnosis of UC primarily relies on invasive examinations, highlighting the necessity for rapid, non-invasive, and low-cost diagnostic methods. This study aims to identify a biomarker that can diagnose and assess UC through bioinformatics analysis of databases. We identified 470 differentially expressed genes (DEGs) from the GSE169568 expression matrix, with 225 genes being up-regulated and 245 down-regulated. Functional analyses using Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and Gene Set Enrichment Analysis demonstrated the enrichment of immune response-related processes. Weighted Gene Co-expression Network Analysis identified a core module associated with UC, comprising 169 genes that exhibited a strong correlation coefficient. By overlapping the UC-related module genes with DEGs, we determined 34 genes. We then assessed the predictive value of UC using the LASSO-Cox method and found that only NDUFB3 and SLIRP were significant. Furthermore, a difference in immune infiltration was observed between the UC and control groups, with macrophages shown to potentially interact with the hub genes. A nomogram model for UC diagnosis was developed based on these two genes, achieving an area under the curve of 0.898. The hub gene model was validated using the GSE94648 dataset, demonstrating good discrimination of the nomogram. Finally, we confirmed that both molecules were expressed at elevated levels in UC patients through clinical peripheral blood specimens. According to our research, NDUFB3 and SLIRP are promising biomarkers for UC and could aid in UC risk prediction. Future research should focus on clinical validation and the exploration of therapeutic interventions targeting the identified pathways and gene modules.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
